Skip to main content
Log in

ASO Author Reflections: Could VAMLA be a Therapeutic Strategy in Selected Patients with Left-sided NSCLC?

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Hurtgen M, Friedel G, Toomes H, Fritz P. Radical video-assisted mediastinoscopic lymphadenectomy (VAMLA)–technique and first results. Eur J Cardiothorac Surg. 2002;21(2):348–51.

    Article  Google Scholar 

  2. Palade E, Passlick B, Osei-Agyemang T, Gunter J, Wiesemann S. Video-assisted vs open mediastinal lymphadenectomy for Stage I non-small-cell lung cancer: results of a prospective randomized trial. Eur J Cardiothorac Surg. 2013;44(2):244–9.

    Article  Google Scholar 

  3. Yoo DG, Kim YH, Kim DK, Kim HR, Park SI. Clinical feasibility and surgical benefits of video-assisted mediastinoscopic lymphadenectomy in the treatment of resectable lung cancer. Eur J Cardiothorac Surg. 2011;40(6):1483–6.

    PubMed  Google Scholar 

  4. Kim HJ, Kim YH, Choi SH, Kim HR, Kim DK, Park SI. Video-assisted mediastinoscopic lymphadenectomy combined with minimally invasive pulmonary resection for left-sided lung cancer: feasibility and clinical impacts on surgical outcomesdagger. Eur J Cardiothorac Surg. 2016;49(1):308–13.

    Article  Google Scholar 

  5. Yun JK, Yoo S, Lee GD, Choi S, Kim HR, Kim DW, Seung-Il Park S-I, Kim Y-H. Comparison of long-term outcomes between minimally invasive pulmonary resection with and without video-assisted mediastinoscopic lymphadenectomy for left-sided lung cancer. Ann Surg Oncol. 2021. https://doi.org/10.1245/s10434-021-11191-8.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Y.-H. Kim MD, PhD.

Ethics declarations

Disclosures

The authors declare no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yun, J.K., Kim, YH. ASO Author Reflections: Could VAMLA be a Therapeutic Strategy in Selected Patients with Left-sided NSCLC?. Ann Surg Oncol 29, 2840–2841 (2022). https://doi.org/10.1245/s10434-021-11232-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-021-11232-2

Navigation